dsip list strategy 14 in. 5 out. This is the peptide RFK referenced—moving access back to ethical supply chains and away from “research-only” sellers. #peptides Doug Drysdale (@insidepharma) / Posts

None of the three GLOW compounds are FDA-approved for injectable human use as of June 2026

For in vivo use, FOXO4-DRI was dissolved in PBS to generate a 5mg/ml stock solution, which was kept on ice until injection

That sorenessa common side effectlessened significantly over the first week, but it has now been four weeks and one day, and I can still feel a slight amount of soreness in that muscle, which surprises me

First-in-human phase I, dose-escalation and -expansion study of telisotuzumab vedotin, an antibody-drug conjugate targeting c-Met, in patients with advanced solid tumors

It has been theorized that BPC 157 therapy could likely represent a bypassing key, by rapidly activating bypassing pathways and abrogating the complex syndrome induced by simultaneous occlusion of essential arterial and venous tributaries